This multicenter study evaluated the effect of variations in arterial input function (AIF) determination on pharmacokinetic (PK) analysis of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data using the shutter-speed model (SSM). Data acquired from eleven prostate cancer patients were shared among nine centers. Each center used a site-specific method to measure the individual AIF from each data set and submitted the results to the managing center. These AIFs, their reference tissue-adjusted variants, and a literature population-averaged AIF, were used by the managing center to perform SSM PK analysis to estimate K
trans
(volume transfer rate constant), v
e
(extravascular, extracellular volume fraction), k
ep
(efflux rate constant), and τ
i
(mean intracellular water lifetime). All other variables, including the definition of the tumor region of interest and precontrast T
1
values, were kept the same to evaluate parameter variations caused by variations in only the AIF. Considerable PK parameter variations were observed with within-subject coefficient of variation (wCV) values of 0.58, 0.27, 0.42, and 0.24 for K
trans
, v
e
, k
ep
, and τ
i
, respectively, using the unadjusted AIFs. Use of the reference tissue-adjusted AIFs reduced variations in K
trans
and v
e
(wCV = 0.50 and 0.10, respectively), but had smaller effects on k
ep
and τ
i
(wCV = 0.39 and 0.22, respectively). k
ep
is less sensitive to AIF variation than K
trans
, suggesting it may be a more robust imaging biomarker of prostate microvasculature. With low sensitivity to AIF uncertainty, the SSM-unique τ
i
parameter may have advantages over the conventional PK parameters in a longitudinal study.